LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX) (the "Company") a diversified,
global medical device company, today announced that it plans to release
financial results for the fourth quarter and fiscal year 2016 after
market close on Monday, February 27, 2017. Brad Mason, Chief Executive
Officer, and Doug Rice, Chief Financial Officer, will host a conference
call and webcast to review the Company's results at 4:30 p.m. EST the
Interested parties may access the conference call by dialing (866)
454-4209 in the U.S. and (913) 312-0839 outside the U.S., and
referencing the conference ID 2108139. A replay of the call will be
available for two weeks by dialing (888) 203-1112 in the U.S. and (719)
457-0820 outside the U.S., and entering the conference ID 2108139. A
webcast of the conference call may be accessed by going to the Company's
website at www.orthofix.com,
by clicking on the Investors link and then the Events and Presentations
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, Texas, the Company
has four strategic business units: BioStim, Biologics, Extremity
Fixation and Spine Fixation. Orthofix products are widely distributed
via the Company's sales representatives and distributors. In
addition, Orthofix is collaborating on research and development
activities with leading clinical organizations such as Brown University,
Sinai Hospital of Baltimore, Cleveland Clinic, Texas Scottish Rite
Hospital for Children, and the Musculoskeletal Transplant Foundation.
For more information, please visit www.orthofix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170216006222/en/
Orthofix International N.V.
Denise Landry, 214-937-2529
Source: Orthofix International N.V.
News Provided by Acquire Media